GALT - Galectin Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts2222
Avg. Estimate-0.12-0.14-0.51-0.46
Low Estimate-0.18-0.19-0.75-0.51
High Estimate-0.07-0.09-0.27-0.41
Year Ago EPS-0.07-0.08-0.38-0.51
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts2222
Avg. EstimateN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.09-0.08-0.14-0.12
EPS Actual-0.07-0.08-0.2-0.06
Difference0.020-0.060.06
Surprise %22.20%0.00%-42.90%50.00%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.12-0.14-0.51-0.46
7 Days Ago-0.12-0.14-0.51-0.46
30 Days Ago-0.12-0.14-0.51-0.53
60 Days Ago-0.14-0.16-0.58-0.61
90 Days Ago-0.14-0.16-0.58-0.61
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/A1
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesGALTIndustrySectorS&P 500
Current Qtr.-71.40%N/AN/A-0.00
Next Qtr.-75.00%N/AN/A0.08
Current Year-34.20%N/AN/A0.03
Next Year9.80%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A